Abstract:Although prognostic factors of nasopharyngeal carcinoma (NPC) have been studied extensively, most of data of these studies are from an endemic area; databases from nonendemic areas are rare. The purpose of this study is to investigate the long-term outcome and prognostic factors analysis for NPC patients receiving 3-dimensional conformal radiation therapy/intensity modulated radiation therapy (3DCRT/IMRT) in a nonendemic area of China. Between January 2004 and December 2011, a total of 393 nonmetastatic and histologically proven NPC patients were identified. All patients received 3DCRT or IMRT. The prognostic factors we analyzed included age, T stage, N stage, lymph node diameter, tumor volume, WHO histology types, and cranial nerve-related symptoms. All patients were staged according to the 7th edition of the American Joint Committee on Cancer (AJCC) system. Factors found to be associated with the endpoints by univariate analyses and then entered into multivariate Cox proportional hazards regression analysis. Continuous variables were divided into 2 subgroups at cut-off values identified by receiver operating characteristic curves and then analyzed. The median follow-up time was 58.3 months (range: 4-130 months). For all patients, the 5-year overall survival (OS), progression-free survival (PFS), locoregional-free survival (LRFS), and distant metastatic-free survival (DMFS) were 71.2%, 60.6%, 84.2%, and 71.6%, respectively. Univariate analyses showed that the risk factors for OS, PFS, and DMFS included T stage (T1-2 vs T3-4), N stage (N0-1 vs N2-3), lymph node diameter (≥3 cm vs <3 cm), cranial nerve symptoms (with vs without), tumor volume (≤40 mL vs >40 mL) and WHO histology types (WHO II vs WHO III). Multivariate analysis indicated that N stage, WHO pathologic types, and tumor volume were 3 independent prognostic factors for OS, PFS, and DMFS. We identified 3 subgroups according to the number of independent risk factors: group 1 (patients with no risk factor), group 2 (patients with only 1 risk factor) and group 3 (patients with more than 2 risk factors). The 5-year OS, PFS, and DMFS for group 1 versus group 2 versus group 3 were 91.5% versus 75.2% versus 49.3%, 82.6% versus 63.5% versus 39.8% and 89.4% versus 77.9% versus 49.4%, respectively (all P<.05) in all patients. N stage, WHO histology types, and tumor volume are independent prognostic indicators for survival outcomes in NPC patients from a nonendemic area of China.

Prognostic Model of Death and Distant Metastasis for Nasopharyngeal Carcinoma Patients Receiving 3DCRT/IMRT in Nonendemic Area of China

Long-term Outcome and Prognostic Factor Analysis for Nasopharyngeal Carcinoma Patients Receiving 3DCRT/IMRT in Nonendemic Area of China

Therapeutic evaluation of induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma with low-risk N stage -a multicenter retrospective study from non-endemic region of China

Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.

Prognostic Analysis of Patients with Locally Advanced Nasopharyngeal Carcinoma Following Intensity Modulated Radiation Therapy.

Neoadjuvant Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma: Defining High-Risk Patients Who May Benefit Before Concurrent Chemotherapy Combined with Intensity-Modulated Radiotherapy.

Prognostic Analysis of 152 Patients with Distant Metastasis after Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma.

Therapeutic Evaluation of Induction Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma With Low-risk <i>N</i> Stage A Multicenter Retrospective Study From Nonendemic Region of China

Prognosis Analyses of 133 Nasopharyneal Carcinona from Northwest China Treated by Intensitymodulated Radiotherapy

Clinical outcome for nasopharyngeal carcinoma with predominantly WHO II histology treated with intensity-modulated radiation therapy in non-endemic region of China.

Clinical outcomes for early-stage nasopharyngeal carcinoma with predominantly WHO II histology treated by intensity-modulated radiation therapy with or without chemotherapy in nonendemic region of China

Failure Patterns and Prognostic Factors for Cervical Node-Negative Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era.

Prognostic and Treatment Guiding Significance of MRI-Based Tumor Burden Features and Nodal Necrosis in Nasopharyngeal Carcinoma

Efficacy of Concurrent Chemoradiotherapy in Subgroups of Stage III Nasopharyngeal Carcinoma: an Analysis Based on 10-Year Follow-Up

Survival and Toxicities of IMRT Based on the RTOG Protocols in Patients with Nasopharyngeal Carcinoma from the Endemic Regions of China.

Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy

Risk factors and prediction-score model for distant metastasis in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy

Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors

Failure Patterns and Survival in Patients with Nasopharyngeal Carcinoma Treated with Intensity Modulated Radiation in Northwest China: A Pilot Study

The Prognostic Value of Volumetric Reduction of the Target Lesions after Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma.

Clinical characteristics and prognostic factors affecting survival after radical radiotherapy for early and late post-treatment metastatic nasopharyngeal carcinoma